Lexaria Announces Results From Animal Study GLP-1-A26-1
Lexaria Bioscience said it is providing results from animal study GLP-1-A26-1, which evaluated multiple formulations.
Story updates
01:11:30 PM UTC
SquawkNews
Lexaria reported animal study results showing certain DehydraTECH-CBD formulations matched a reference in blood absorption and one achieved 566% higher mean brain levels at 8 hours; DehydraTECH-semaglutide showed non-inferior plasma exposure to reference but brain levels were below assay quantitati…